In conclusion, our combined bioinformatics and experimental approach provides evidence that KLK10 is a downstream target for multiple miRNAs in ovarian cancer, with a positive proliferative effect on cancer cell proliferation. Here, KLK10 is linked to ovarian carcinoma.